UBS Group AG - MEDICAL TRANSCRIPTION BLG CO ownership

MEDICAL TRANSCRIPTION BLG CO's ticker is MTBC and the CUSIP is 58464J105. A total of 1 filers reported holding MEDICAL TRANSCRIPTION BLG CO in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MEDICAL TRANSCRIPTION BLG CO
ValueSharesWeighting
Q4 2018$13,000
+1200.0%
3,484
+1505.5%
0.00%
Q2 2018$1,000
-87.5%
217
-93.0%
0.00%
Q4 2017$8,000
+14.3%
3,096
-38.5%
0.00%
Q3 2017$7,000
+133.3%
5,032
+36.9%
0.00%
Q3 2016$3,000
+50.0%
3,675
+94.2%
0.00%
Q1 2016$2,0000.0%1,892
+70.5%
0.00%
Q3 2015$2,0000.0%1,110
+5.8%
0.00%
Q2 2015$2,000
+100.0%
1,049
+333.5%
0.00%
Q1 2015$1,0002420.00%
Other shareholders
MEDICAL TRANSCRIPTION BLG CO shareholders Q1 2019
NameSharesValueWeighting ↓
BURNS J W & CO INC/NY 14,158$37,0000.01%
QCI ASSET MANAGEMENT INC/NY 19,158$50,0000.01%
Virtu Financial LLC 10,825$28,0000.00%
PANAGORA ASSET MANAGEMENT INC 26,784$70,0000.00%
MORGAN STANLEY 250$1,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 12,514$33,0000.00%
VANGUARD GROUP INC 91,380$238,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 750$2,0000.00%
UBS Group AG 3,096$8,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 30,694$80,0000.00%
View complete list of MEDICAL TRANSCRIPTION BLG CO shareholders